相关实验视频
Updated: Jun 12, 2025

08:05
Murine Model of Allergen Induced Asthma
Published on: May 14, 2012
40.2K
伴并发性食物过敏是否会影响喘患者对奥马利祖马布的反应?
Alessandro Fiocchi1, R Sharon Chinthrajah2, Ignacio J Ansotegui3
1Bambino Gesù Childrens' Hospital IRCCS, Rome, Italy.
Journal of asthma and allergy
|September 23, 2024
概括
奥马利祖马布有效改善了伴随性食物过敏患者的喘控制和生活质量. 在这些患者中,这种治疗显示出一致的益处,而不管这些患者的阿托皮增加.
科学领域:
- 免疫学 免疫学 免疫学
- 过敏和喘研究研究
- 药理学 药理学是指药理学的学科.
背景情况:
- 食物过敏和喘经常同时存在,可能会使这两种情况都变得更糟.
- 奥马利祖马布是一种抗免疫球蛋白E (IgE) 抗体,是治疗伴随性喘和食物过敏的潜在治疗药物.
- 在患有喘和食物过敏的患者中,Omalizumab的疗效存在有限的研究.
研究的目的:
- 分析阿马利祖马布在喘患者的疗效,由伴随性食物过敏的存在分层.
- 评估奥马利祖马布对以患者为中心的治疗结果,医疗保健资源利用率和这一群体中喘控制的影响.
主要方法:
- 随机对照试验 (RCT) 和现实世界观察性研究的后期分析.
- 根据医生报告的食物过敏状态来分层喘患者.
- 评估一般性,喘特异性和医疗保健资源利用结果.
主要成果:
- 患有并发性食物过敏的患者在基线时表现出更高的亚托皮.
- 奥马利祖马布持续改善了喘特异性生活质量,生产力和喘控制.
- 医疗保健资源的使用,包括紧急访问和住院治疗,由奥马利祖马布减少.
- 在患有并发性食物过敏的患者中没有观察到奥马利祖马布疗效的降低.
结论:
- 奥马利祖马布在改善伴随性食物过敏患者的喘相关结果方面表现出一致的有效性.
- 食物过敏的存在并没有减少奥马利祖马布在喘管理方面的益处.
- 奥马利祖马布是治疗喘和食物过敏的潜在选择.
相关概念视频
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
245
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
245
Asthma-I: Introduction
2.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
Allergic Reactions
27.3K
Overview
27.3K
Asthma-III: Symptoms and Complications
2.5K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
2.5K
Antiasthma Drugs: Leukotriene Modifiers
252
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
252
Asthma: Pathogenesis and Management
364
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
364

